Search

Your search keyword '"Zarrinfar H"' showing total 102 results

Search Constraints

Start Over You searched for: Author "Zarrinfar H" Remove constraint Author: "Zarrinfar H"
102 results on '"Zarrinfar H"'

Search Results

1. The Identification of Nocardia in BAL Specimens of Bronchoscopic Patients by Using Classical and Molecular Methods

4. Mixinyeast: A multicenter study on mixed yeast infections

5. Genetic diversity and antifungal susceptibility patterns of aspergillus nidulans complex obtained from clinical and environmental sources

6. Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology

8. Mucormycosis in Iran: A six-year retrospective experience

9. Molecular Identification of Candida Species in Bronchoalveolar Lavage Specimens of Hospitalized Children with Pulmonary Disorders.

10. Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis

11. Mucormycosis in ImmunocompromisedPpatients

12. In vitro activities of eight antifungal drugs against 104 environmental and clinical isolates of Aureobasidium pullulans

14. Mycological Microscopic and Culture Examination of 400 Bronchoalveolar Lavage (BAL) Samples.

15. In VitroActivities of Eight Antifungal Drugs against 104 Environmental and Clinical Isolates of Aureobasidium pullulans

16. Comparision of MICs of some Iranian herbal essences against azole resistance and azole susceptible of Candida albicans

17. Mycological microscopic and culture examination of 400 bronchoalveolar lavage (BAL) samples

18. The identification of nocardia in bal specimens of bronchoscopic patients by using classical and molecular methods

19. Pneumocystis jirovecii colonization in non-HIV-infected patients based on nested-PCR detection in bronchoalveolar lavage samples

21. Inhibitory effect of Nigella sativa oil loaded to liposomal nanocarriers on Candida parapsilosis isolates.

22. Epidemiology of Candidemia in Mashhad, Northeast Iran: A Prospective Multicenter Study (2019-2021).

23. Inappropriate treatment of pulmonary aspergillosis caused by Aspergillus flavus in susceptible pediatric patients: a case series.

24. Molecular Epidemiology and Antifungal Susceptibility Profile in Nakaseomyces glabrata Species Complex: A 5-Year Countrywide Study.

25. COVID-19 associated candidemia: From a shift in fungal epidemiology to a rise in azole drug resistance.

26. Hematological Indices in COVID-19 Patients with Rhinosinusitis Mucormycosis.

27. Iranian National Survey on Tinea Capitis: Antifungal Susceptibility Profile, Epidemiological Characteristics, and Report of Two Strains with a Novel Mutation in SQLE Gene with Homology Modeling.

28. Antifungal activity of three different varieties of Capsicum annuum against clinical isolates of Candida species.

29. In vitro antifungal susceptibility profile of Iranian Fusarium isolates: Emphasising on the potent inhibitory effect of efinaconazole compared to other drugs.

30. The effect of synbiotic adjunct therapy on clinical and paraclinical outcomes in hospitalized COVID-19 patients: A randomized placebo-controlled trial.

31. Five-year surveillance study of clinical and environmental Triazole-Resistant Aspergillus fumigatus isolates in Iran.

32. Molecular identification and genotyping of Acanthamoeba spp., in bronchoalveolar lavage fluid from immunocompetent patients with chronic respiratory disorders (CRD).

33. Impact of a health educational interventional program on reducing the head lice infestation among pupils in an elementary school of a sub-tropical region: a quasi-experimental study.

34. In Vitro Antifungal Susceptibility Profile of Miltefosine against a Collection of Azole and Echinocandins Resistant Fusarium Strains.

35. First report of emerged pulmonary lophomoniasis in two Afghanian medical tourists.

36. Update on dermatophytosis in Mashhad, Northeastern Iran, emergence of infection with Trichophyton persicum .

37. First report of Lophomonas infection in a patient with AML-2 from Qeshm Island, Persian Gulf, southern Iran.

38. The effect of biosynthesized selenium nanoparticles on the expression of CYP51A and HSP90 antifungal resistance genes in Aspergillus fumigatus and Aspergillus flavus.

39. Interventional Effect of Nanosilver Paint on Fungal Load of Indoor Air in a Hospital Ward.

40. In vitro antifungal susceptibility patterns of Trichophyton benhamiae complex isolates from diverse origin.

41. Discovery of New Trichophyton Members, T. persicum and T. spiraliforme spp. nov., as a Cause of Highly Inflammatory Tinea Cases in Iran and Czechia.

42. First report of invasive Aspergillus rhinosinusitis in a critically ill COVID-19 patient affected by acute myeloid leukemia, northeastern Iran.

43. High incidence of azole resistance among Candida albicans and C. glabrata isolates in Northeastern Iran.

44. Molecular Diversity of Aspergilli in Two Iranian Hospitals.

45. Green synthesis of colloidal selenium nanoparticles in starch solutions and investigation of their photocatalytic, antimicrobial, and cytotoxicity effects.

46. Successful treatment of pulmonary aspergillosis due to Aspergillus fumigatus in a child affected by systemic lupus erythematosus: A case report from Northeastern Iran.

47. Diversity of Geophilic Dermatophytes Species in the Soils of Iran; The Significant Preponderance of Nannizzia fulva .

48. Candidemia among Iranian Patients with Severe COVID-19 Admitted to ICUs.

49. Antifungal Activities of Curcuminoids and Difluorinated Curcumin Against Clinical Dermatophyte Isolates.

50. Antifungal Activity of Curcuminoids and Difluorinated Curcumin Against Clinical Isolates of Candida Species.

Catalog

Books, media, physical & digital resources